Article Details

Analysts at StockNews.com rate Kamada (NASDAQ:KMDA) as a buy. - Best Stocks

Retrieved on: 2022-11-23 03:38:53

Tags for this article:

Click the tags to see associated articles and topics

Analysts at StockNews.com rate Kamada (NASDAQ:KMDA) as a buy. - Best Stocks. View article details on hiswai:

Excerpt

now holds a total of 68,889 shares of the biotechnology company's stock, which are worth $380,000. Goldman Sachs Group Inc. boosted the proportion of ...

Article found on: beststocks.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up